SCHEMBL12830488

SCHEMBL12830488

O=C(Nc1csc(-c2c[nH]c3ccccc23)c1C(=O)O)c1cc2ccccc2o1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 12/20 0.46
RAB9A P51151 11/20 0.46
TP53 P04637 6/20 0.46
SMN1; SMN2 Q16637 6/20 0.46
NFKB1 P19838 2/20 0.46
NFKB2 Q00653 2/20 0.46
RELA Q04206 2/20 0.46
PKM P14618 1/20 0.46
MAOB P27338 1/20 0.45
KDM4E B2RXH2 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ATM Q13315 2/20 0.43
POLB P06746 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2179992 0.84 MAOB (0.48) NPC1RAB9ATP53SMN1; SMN2NFKB1
SCHEMBL12830443 0.83 RAB9A (0.55) NPC1RAB9ATP53SMN1; SMN2NFKB1
SCHEMBL12756457 0.81 NPC1 (0.54) NPC1RAB9ATP53SMN1; SMN2NFKB1
SCHEMBL12756816 0.79 HDAC1 (0.48) NPC1RAB9ATP53SMN1; SMN2NFKB1
SCHEMBL12830449 0.78 HDAC2 (0.52) NPC1RAB9ATP53SMN1; SMN2NFKB1
SCHEMBL12756428 0.77 RAB9A (0.53) NPC1RAB9ATP53SMN1; SMN2NFKB1
SCHEMBL12756440 0.77 RAB9A (0.53) NPC1RAB9ATP53SMN1; SMN2NFKB1
SCHEMBL12830020 0.77 RAB9A (0.50) NPC1RAB9ATP53SMN1; SMN2NFKB1
SCHEMBL12756433 0.77 RAB9A (0.50) NPC1RAB9ATP53SMN1; SMN2NFKB1
SCHEMBL12830138 0.77 RAB9A (0.50) NPC1RAB9ATP53SMN1; SMN2NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 WO disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 NPC1 262/4885RAB9A 1174/4885TP53 2681/4885
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 NPC1 262/4885RAB9A 1174/4885TP53 2681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.